This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 10/27/2020
Location: Virtual
Subject: Intergovernmental Working Meeting on Drug Compounding
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, and other invited guests

Event Date: 10/27/2020
Location: Virtual
Subject: Medical Device User Fee Amendments Public Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, media, and other registered guests

Event Date: 10/27/2020
Location: Virtual
Subject: COVID-19 Vaccine
FDA Participant/Group: COLIN ROM; PETER MARKS; NICHOLAS ALEXANDER; BETH FRITSCH; DAYLE CRISTINZIO; MICHELLE ADAMS;
Non FDA Participant/Group: Several members from the State Health Departments and Association of State and Territorial Health Officials

Event Date: 10/29/2020
Location: Virtual
Subject: COVID-19 Vaccine
FDA Participant/Group: PETER MARKS; COLIN ROM; DAYLE CRISTINZIO; BETH FRITSCH;
Non FDA Participant/Group: Several members from the Association of American Medical Colleges (AAMC) and AAMC leadership

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 10/28/2020
Location: Virtual
Subject: Aetion Real-world Evidence Summit; Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, industry, and other stakeholders

Event Date: 10/28/2020
Location: Virtual
Subject: Clinical Trials Oncology; Keynote Fireside Chat: The Impact of “Big Data” and Data Analytics on Trial Design and Execution
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and other stakeholders

Event Date: 10/30/2020
Location: Virtual
Subject: BioNJ C-Suite Summit; Fireside Chat: The Regulatory Horizon
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 10/26/2020
Location: Virtual
Subject: New Era of Smarter Food Safety 100 Day Webinar
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members from food and beverage industry, academia, state and federal government

Event Date: 10/27/2020
Location: Virtual
Subject: International Association for Food Protection 2020 Conference; Presenter and Q&A Session: Food Safety Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Members from food and beverage industry, academia, state and federal government, and international stakeholders

Event Date: 10/27/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: JEFFREY FARRAR;
Non FDA Participant/Group: Karen Ross, Natalie Krout (California Department of Food and Agriculture);

Event Date: 10/28/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: JEFFREY FARRAR;
Non FDA Participant/Group: Mark Killian (Arizona Department of Agriculture);

Event Date: 10/28/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members from the Washington Red Raspberry Commission and American Frozen Food Institute

Event Date: 10/30/2020
Location: Virtual
Subject: Food Traceability Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; SUSAN KELLY; CAITLIN BOON; SHARON MAYL; ANDREW KENNEDY;
Non FDA Participant/Group: Bob Carpenter, Marshall Keener, Siobhan O'Bara (GS1 US);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 10/27/2020
Location: Virtual
Subject: World Health Organization Member State Mechanism on Substandard and Falsified Medical Products Steering Committee Meeting
FDA Participant/Group: RUSSELL CAMPBELL, SEMA HASHEMI, KATHRYN HUGHES
Non FDA Participant/Group: V.G. Somani (Central Drugs Standard Control Organization, India), Leonardo Dutra Rosa (Brazilian Health Regulatory Agency (ANVISA)), and other steering committee members

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/27/2020
Location: Virtual
Subject: Medical Device User Fee Amendments for Fiscal Years 2023 Through 2027 Public Meeting; CBER Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from industry, government, and other stakeholders

Event Date: 10/29/2020
Location: Virtual
Subject: New Jersey Institute of Technology Webinar; Opening Remarks: New Jersey: A Rising Cell and Gene Therapy Hub
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from industry, government, and other stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 10/27/2020
Location: Virtual
Subject: Medical Device User Fee Amendments (MDUFA) Five Public Meeting: Center for Devices and Radiological Health Update
FDA Participant/Group: STEPHEN HAHN; LAUREN ROTH; DAVINA MARANO; PETER MARKS; ELIZABETH HILLEBRENNER; NICOLE ELLIS; BRITTANY SCHUCK;
Non FDA Participant/Group: Industry, advocacy organizations, government, and other stakeholders

Event Date: 10/29/2020
Location: Virtual
Subject: Healthcare Sector Coordinating Council Semi-Annual Membership Meeting: Fireside Chat
FDA Participant/Group: SUZANNE SCHWARTZ;
Non FDA Participant/Group: Medical device and health IT companies, direct patient care entities, plans and payers, labs, blood and pharmaceutical companies, and numerous advisor organizations and government partners

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event